FOX BIZ NEWS: Should Investors Like Bristol-Myers' Buyout of Celgene?
Should Investors Like Bristol-Myers' Buyout of Celgene?
The pharmaceutical giant’s $74 billion bid for the biotechnology player sent the acquirer’s shares significantly lower, but that’s hardly unusual.
via FOX BUSINESS NEWS https://fxn.ws/2Ty5ty5
posted by Mjplaystore @ 00:06
0 Comments
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home